Global Implantable Drug Delivery Devices Market, by Product Type (Drug infusion pumps, Intraocular drug delivery devices, Contraceptive drug delivery devices and Stents), by Technology (Biodegradable Implants and Non Bio degradable Implants), by Application (Ophthalmology, Cardiovascular, Birth Control/Contraception and Others) and by Region - Trends and Forecast till 2025

  • Published On : Dec 2017 |
  • Pages : 144 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Implantable drug delivery devices – Bid good bye to painful needles

Implantable drug delivery devices are used to administer drugs and fluids without the repeated insertion of needles. This product circumvents the need for patients to be hospitalized for intravenous infusion. Recent discovery and developments in genomics, proteomics and biotechnology have led to emerging classes of novel pharmaceutical compounds like siRNAs, small molecules and other nanoparticle based products that are not compatible with standard oral formulations.  Instead these drugs are well suited for parenteral administration for their desired systemic effect. Implantable drug delivery devices can be aptly utilized for delivery of such drugs, Over last decade there has been increasing convergence between drug therapies and implantable devices, which include devices such as, osmotic pumps and implantable rods that deliver drugs on specific targeted area (anticancer agents, hormones and vaccine).

Increase in acceptance and patient compliance for implantable drug delivery devices to propel the market

Implantable drug delivery devices offer several advantages over conventional oral or parenteral dosage form such as protection against gastrointestinal tract denaturation and higher absorption across the wall of intestine or stomach. Secondly, the amount of drug reaching the target should be large to obtain the desired therapeutic effect. Another factor that increases acceptance and patient compliance over traditional mode of administration of drug is the biodegradable systems which have gain momentum over non-biodegradable delivery system due to the fact that inert polymer used for the fabrications of the device eventually gets absorbed and excreted by the body alleviating the need of surgical removal of implant after therapy. These factors together are expected to propel the market growth in future forecast. Moreover, factors like device failure, and biocompatibility is expected to restrain the overall market growth.

The global implantable drug delivery device market was valued at US$ 9,554.4 million in 2016 and is expected to witness a robust CAGR of 7.6 % over the forecast period (2017-2025).

Global Implantable Drug Delivery Devices Market Share, By Region, 2016

implantable-drug-delivery-devices-market

Source: Coherent Market Insights (2017)

Increase in global burden of non-communicable diseases is expected to propel implantable drug delivery devices market

According to a report by World Health Organization (WHO), 2017, chronic diseases are the major cause of disabilities worldwide. The estimated global burden by 2020 is 60%. Moreover, 73% of deaths in 2020 is expected to be due to chronic diseases. Four of the most prominent chronic diseases are cardiovascular, cancer, pulmonary and type 2 diabetes. Implantable drug delivery devices offers unique patients solutions for chronic diseases. For instance, in October, 2017, Encellin, has received an exclusive worldwide right for a proprietary cell encapsulated technology by developed UC San Francisco aiming to improve cell transplant without the need of immunosuppressive drugs. The Encellin device is encapsulated with glucose sensitive islet cells in a pouch, and is implanted under the skin, enabling it to regulate glucose level. Similarly, In 2015 Intarcia Therapeutics, developed a drug eluting non-biodegradable device ITC650 for the treatment of diabetes, which consists of osmotic pump small titanium alloy reservoir delivering a steady flow of a glucagon-like peptide-1 receptor agonist, for 12 months.

Geographically, North America is expected to be the dominating region globally in implantable drug delivery devices market owing to high demand for self-administration products and new product launches in this region. For instance, in 2016, U.S. FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome. The major market players in the global implantable drug delivery devices market include Boston Scientific, Abbott Laboratories, Medtronic, Merck & Co., Bausch & Lomb Inc., Allergan, Inc., Psivida Corp., and Bayer Healthcare.

Implantable drug delivery devices market is mainly driven by the management of chronic diseases such as cancer, cardiovascular diseases (CVD), diabetes, and birth control contraceptives. These devices offers several advantages over conventional drug dosage forms, mainly due to their site specific drug delivery. They also allow significantly lower doses of drugs which minimizes the potential side effects.

Furthermore, in addition to subcutaneous implants, new drug delivery form such as intrauterine (IU) and intravaginal (IV) rings are finding increasing applications in woman health, due to their durability and efficiency in birth control.

High incidence of chronic ailments, woman health diseases, and increase in acceptance of FDA approved implantable drug delivery devices are some of the factors fueling growth of the implantable drug delivery devices market in the near future.

Market Dynamics

Recent discoveries and developments in the field of biotechnology, proteomic, and genomics have led to the development of siRNAs, which are small molecules and other nanoparticles. These drugs are delivered directly to the site for the desired systemic effect. Implantable drug delivery devices are used as conventional drugs are not compatible with standard oral formulations.

Furthermore, high acceptance rate of biodegradable implantable drug delivery devices over non-biodegradable devices due to their easy absorption by the body and alleviating need of surgery after therapy, is expected to propel the market growth.

However, device failure and biocompatibility issue is expected to hamper growth of the market. Manufacturers need to be cautious in adhering to quality guidelines in order to avoid recall of devices.

Key features of the study:

  • This report provides an in-depth analysis of Global Implantable Drug Delivery Devices Market, provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the Global Implantable Drug Delivery Devices Market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Merck & Co., Bausch & Lomb Inc., Medtronic Inc., Allergan, Inc., Psivida Corp., Bayer Healthcare, Boston Scientific Corporation, and Abbott Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The Global Implantable Drug Delivery Devices Market report caters to various stakeholders in this industry including investors, suppliers, implantable drug delivery device manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the implantable drug delivery devices market.

Detailed Segmentation:

  • Global Implantable Drug Delivery Devices Market, By Product Type:
    • Drug infusion pumps
    • Intraocular drug delivery devices
    • Contraceptive drug delivery devices
    • Stents
  • Global Implantable Drug Delivery Devices Market, By Technology:
    • Biodegradable Implants
    • Non-Biodegradable Implants
  • Global Implantable Drug Delivery Devices Market, By Application:
    • Ophthalmology
    • Cardiovascular
    • Birth control/Contraception
    • Others
  • Global Implantable Drug Delivery Devices Market, By Geography:
    • North America
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • By Country
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • Country
        • U.K.
        • Germany
        • Italy
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Drug infusion pumps
        • Intraocular drug delivery devices
        • Contraceptive drug delivery devices
        • Stents
      • By Technology
        • Biodegradable Implants
        • Non-Biodegradable Implants
      • By Application
        • Ophthalmology
        • Cardiovascular
        • Birth control/Contraception
        • Others 
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Merck & Co.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Medtronic Inc.
    • Allergan, Inc.
    • Psivida Corp.
    • Bayer Healthcare
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Bausch & Lomb Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Technology
      • Market Snippet By Application
      • Market Snippet By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • Technology Evolution
  4. Global Implantable Drug Delivery Devices Market, By Product Type, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2015 - 2025
      • Segment Trends
    • Drug infusion pumps
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Intraocular drug delivery devices
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Contraceptive drug delivery devices
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Stents
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  5. Global Implantable Drug Delivery Devices Market, By Technology, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2015 - 2025
      • Segment Trends
    • Biodegradable Implants
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Non-Biodegradable Implants
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  6. Global Implantable Drug Delivery Devices Market, By Application, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2015 - 2025
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Birth control/Contraception
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  7. Global Implantable Drug Delivery Devices Market, By Regions, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2015 – 2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Technology, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Application, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Merck & Co.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bausch & Lomb Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medtronic Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Allergan, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Psivida Corp.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bayer Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 38 market data tables and 28 figures on "Implantable Drug Delivery Devices Market” - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.